Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Advances in HIV treatment uncover a new issue: Aging
• Pediatric influenza immunization: Gaining ground, but more to do Carol J. Baker, MD
• WHO: Additional MERS cases in Saudi Arabia
• PrEP cost-effective in discordant, regular MSM partnerships
• China reports human infection with new avian influenza virus
• AASLD, IDSA, IAS-USA release guidelines, launch website for management of HCV
• Children may be more vulnerable to disease outbreaks caused by harmful algal blooms
• High levels of depressive symptoms may be linked to delayed ART
• CDC panels establish anthrax prevention, treatment guidelines
• European injectional anthrax cases linked to strains from 2009 outbreak
• Investigators link outbreaks of fungal endophthalmitis to medications from same compounding pharmacy
• CDC collaborations succeed at protecting against infectious disease threats
• ACIP releases 2014 recommended adult immunization schedule
• Ineffective study endpoints, poor dose selection account for most delays in FDA NDAs
• Q fever in Thailand suggests additional vectors responsible for spread Burke A. Cunha, MD, MACP
• MERS vs. SARS: Compare and contrast Donald Kaye, MD, MACP; Marjorie P. Pollack, MD
• FDA clears MRSA test for marketing
• FDA warns against products with more than 325 mg acetaminophen
• FDA: Texas oysters linked to six norovirus cases
• Oral daclatasvir plus sofosbuvir highly effective in HCV patients
• Prevalence of hepatitis C in Swiss MSM similar to general population
• Earlier stage at diagnosis not related to increased HIV viral suppression
• HA-MRSA infection rate declined in VA long-term care facilities
• Hospital water faucet taps contaminated with bacteria
• Lymphopenia associated with RSV lower respiratory infection after cell transplant
• Critically ill patients may not be receiving enough antibiotics
• HCV testing rates low among IDUs in Thailand
• Measuring antibody levels prudent after some vaccinations in patients with HIV
• Antibiotic exposure, renal disease linked to MDR gram-negative bacteremia in neonates
• Clinical changes likely led to reduction of invasive candidiasis rates
• HCV prevalence among Hispanics varies by group
• HIV treatment outcomes worse for women transitioning from jail
• HPV vaccination refusal, delay continued by some parents
• HRV common cause of severe lower respiratory tract infections
• Inappropriate antibiotic use still prevalent for adults in ED
• Intrauterine, postnatal growth unaffected by exposure to HIV, antenatal antiretrovirals
• Longer hospitalization likely with hospital-onset flu vs. community-onset cases
• Long-term CV events risk low among patients with Kawasaki disease
• Lymphocyte count associated with infection risk during interferon treatment
• More young people started ART after 2009 guidelines change
• Once-daily extended-release nevirapine effective in treatment of children with HIV-1
• Oral antivirals, ribavirin efficacious in patients with HCV genotype 1
• PCV7 increased bacterial diversity in healthy children
• Seasonal pneumococcal carriage rates varied in day care centers
• TB more likely in infants exposed to HIV-1
• XDR-TB patients in South Africa often released without cure, still infectious
• Clinical trial evidence supporting FDA approvals varies widely
• Improper use of biocides may increase antimicrobial resistance
• SHEA releases guidelines for HCW attire in clinical settings
• Persistent anal HPV in women associated with certain sexual behaviors
• Xpert TB test showed limited effect in high-resource, low-incidence settings
• Treating severe malaria: What to know about artesunate Kimberly Boeser, PharmD, MPH, BCIDP; Dayla Boldt, PharmD